| Risk factors and biomarkers for immune-related adverse events: a practical guide to identifying high-risk patients and rechallenging immune checkpoint inhibitors A Chennamadhavuni, L Abushahin, N Jin, CJ Presley, A Manne Frontiers in immunology 13, 779691, 2022 | 133 | 2022 |
| Biliary tract cancers: treatment updates and future directions in the era of precision medicine and immuno-oncology A Manne, E Woods, A Tsung, A Mittra Frontiers in Oncology 11, 768009, 2021 | 27 | 2021 |
| Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review Y Fahmawi, Y Campos, M Khushman, O Alkharabsheh, A Manne, ... Clinical Pharmacology: Advances and Applications, 127-131, 2019 | 26 | 2019 |
| Changing landscape of systemic therapy in biliary tract cancer E Woods, D Le, BK Jakka, A Manne Cancers 14 (9), 2137, 2022 | 21 | 2022 |
| Understanding the clinical impact of MUC5AC expression on pancreatic ductal adenocarcinoma A Manne, A Esnakula, L Abushahin, A Tsung Cancers 13 (12), 3059, 2021 | 19 | 2021 |
| Therapeutic options for ampullary carcinomas. A review DKR Regalla, R Jacob, A Manne, RK Paluri Oncology Reviews 13 (2), 2019 | 18 | 2019 |
| Obesity is associated with poor surgical outcome in Crohn’s disease TA Malik, A Manne, RA Oster, A Eckhoff, S Inusah, AM Gutierrez Gastroenterology research 6 (3), 85, 2013 | 10 | 2013 |
| Clinical and hematological predictors of high-grade immune-related adverse events associated with immune checkpoint inhibitors A Manne, MS Mulekar, DE Escobar, A Alsayed, G Sharma, ... Journal of Clinical Medicine Research 13 (5), 268, 2021 | 8 | 2021 |
| Predictors of outcome of rectovaginal fistula surgery in women with Crohn’s disease A Manne, MB Ahmed, TA Malik Journal of Clinical Medicine Research 8 (2), 126, 2016 | 8 | 2016 |
| Stereotactic body radiation therapy (SBRT) plus immune checkpoint inhibitors (ICI) in hepatocellular carcinoma and cholangiocarcinoma J Jiang, DA Diaz, SP Nuguru, A Mittra, A Manne Cancers 15 (1), 50, 2022 | 7 | 2022 |
| Current landscape of immune checkpoint inhibitor therapy for hepatocellular carcinoma SM Ruff, A Manne, JM Cloyd, M Dillhoff, A Ejaz, TM Pawlik Current Oncology 30 (6), 5863-5875, 2023 | 6 | 2023 |
| Risk Factors and Biomark‑ers for Immune‑Related Adverse Events: A Practical Guide to Identifying High‑Risk Patients and Rechallenging Immune Checkpoint Inhibitors. Front … A Chennamadhavuni, L Abushahin, N Jin, CJ Presley, A Manne | 6 | 2022 |
| Is Cell-Free DNA Testing in Pancreatic Ductal Adenocarcinoma Ready for Prime Time? A Sheel, S Addison, SP Nuguru, A Manne Cancers 14 (14), 3453, 2022 | 5 | 2022 |
| The clinical benefit of adjuvant therapy in long-term survival of early-stage ampullary carcinoma: a single institutional experience A Manne, H Hatic, P Li, R Jacob, G Williams, R Paluri Journal of Clinical Medicine Research 12 (9), 560, 2020 | 5 | 2020 |
| Selecting the first line treatment in non-metastatic hepatocellular carcinoma-comparing clinical practice guidelines S Jogi, R Varanai, SS Bantu, A Manne Oncology Reviews 14 (2), 2020 | 4 | 2020 |
| Obesity and outcome of Crohn’s associated perianal fistula surgery: a case-control study A Manne, AS Khan, TA Malik Gastroenterology research 8 (6), 291, 2015 | 4 | 2015 |
| Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma AH Shannon, A Manne, DA Diaz Pardo, TM Pawlik Frontiers in Oncology 13, 1193762, 2023 | 3 | 2023 |
| Predictive Value of MUC5AC Signature in Pancreatic Ductal Adenocarcinoma: A Hypothesis Based on Preclinical Evidence A Manne, A Kasi, AK Esnakula, RK Paluri International journal of molecular sciences 24 (9), 8087, 2023 | 3 | 2023 |
| Compliance to the American Association for the Study of Liver Diseases (AASLD) guidelines and its impact on overall survival in patients with hepatocellular carcinoma. A Manne, MS Mulekar, DE Escobar, P Prodduturvar, Y Fahmawi, ... Journal of Clinical Oncology 38 (15_suppl), e16609-e16609, 2020 | 2 | 2020 |
| The pattern of mucin 5AC (MUC5AC) expression using immunohistochemistry and its prognostic significance in patients with pancreatic ductal adenocarcinoma. A Manne, W Mneimneh, O Elkadi, DE Escobar, J Coley, GB Guzman, ... Journal of Clinical Oncology 38 (15_suppl), e16756-e16756, 2020 | 2 | 2020 |
